Biotech / Pharma
Tikva Allocell
Biotech / Pharma
[subscription] Tikva Allocell, a three-year-old Singapore startup developing donor-derived engineered T-cell therapies for solid tumors, raised $8 million in Series A led by Kantharos Capital.. Tikva Allocell. EU Regulators Fine Google $1B
Founded
Region
Investors
People